Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04353960 · ClinicalTrials.gov registry record
The Alaska Oculocardiac Reflex Study
A clinical trial of Bradycardia and Strabismus, sponsored by Alaska Blind Child Discovery.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT04353960: Recruiting study of Bradycardia and Strabismus, sponsored by Alaska Blind Child Discovery.
NCT04353960 is a study of Bradycardia and Strabismus that is actively recruiting participants, run by Alaska Blind Child Discovery. The registered enrollment target is 4,000 participants, roughly in line with the 4,275-participant average among 29 other Bradycardia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04353960, a study of Bradycardia and Strabismus, is actively recruiting participants, sponsored by Alaska Blind Child Discovery.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery. \*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, Anchorage, Alaska (letter 10/2020).\*
Primary Outcome
Continuous variable of percent change in heart rate from stable pre-heart rate to greatest change heart rate during strabismus surgery
Conditions Studied
Interventions
- DIAGNOSTIC_TEST electrocardiograph
Study Locations (1)
Alaska
- Alaska Children's EYE & Strabismus - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1992-09-01 |
| Est. Completion | 2035-12-31 |
What NCT04353960 shows while recruiting
NCT04353960 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 4,275-participant average among 29 other Bradycardia trials with a reported enrollment target.
The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which electrocardiograph is the first listed.
NCT04353960 reports a single indexed study location in Alaska.
Frequently Asked Questions
What is clinical trial NCT04353960 about?
NCT04353960 is a clinical study titled "The Alaska Oculocardiac Reflex Study". Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery. \*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, A...
What is the current status of trial NCT04353960?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 1992-09-01. Estimated completion is 2035-12-31.
What conditions does trial NCT04353960 study?
This clinical trial studies the following conditions: Bradycardia, Strabismus.
What interventions are being tested in trial NCT04353960?
The interventions under investigation include: electrocardiograph (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04353960?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04353960 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04353960's enrollment target sits among peer trials
4,000 5th of 29 higher than 25 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
-
Aveir VR Coverage With Evidence Development Post-Approval Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI